Private Medicare Plans Must Cover Biogen’s ALS Drug

Published on December 12, 2024

The Centers for Medicare & Medicaid Services has directed private insurers providing Medicare Advantage plans to cover Biogen’s amyotrophic lateral sclerosis drug Qalsody after finding instances of coverage denial. Qalsody received the U.S. Food and Drug Administration’s…

Read Full Article (External Site)